BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xia Y, Hu Y, Ma JH. Premixed insulin: Advantages, disadvantages, and future. World J Diabetes 2025; 16(3): 102526 [PMID: 40093285 DOI: 10.4239/wjd.v16.i3.102526]
URL: https://www.wjgnet.com/1948-9358/full/v16/i3/102526.htm
Number Citing Articles
1
Miao Yu. iGlarLixi: A titrateable fixed‐ratio combination of basal insulin + GLP‐1 receptor agonist—An effective type 2 diabetes treatment option in ChinaDiabetes, Obesity and Metabolism 2025; 27(S10): 15 doi: 10.1111/dom.70192
2
Eveline M Anto, Adheena M, P. Jayamurthy. ER stress: A putative therapeutic target for diabetes mellitusBiochemical and Biophysical Research Communications 2026; 818: 153773 doi: 10.1016/j.bbrc.2026.153773
Write to the Help Desk